BALTIMORE--(BUSINESS WIRE)--Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Series A financing ...
Investment supports platform innovation, commercial scaling, and new service development; Infinity acquires the assets of Serimmune, Inc. BALTIMORE--(BUSINESS WIRE)-- Infinity Bio, a biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results